Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma

August 19, 2024 | Comments Off on Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma

Annals of Surgical Oncology 2024 August 10 [Link] Akifumi Nakamura, Masaki Hashimoto, Ayumi Kuroda, Kyoshiro Takegahara, Akihiro Fukuda, Seiji Matsumoto, Nobuyuki Kondo, Toshiyuki Minami, Kazuhiro Kitajima, Kozo Kuribayashi, Takashi Kijima,…

Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience

August 16, 2024 | Comments Off on Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience

Journal of the College of Physicians and Surgeons 2024 August [Link] Yasin Sezgin, Ogur Karhan, Serdar Ileri, Senar Ebinc, Sezai Tunc, Zuhat Urakci Abstract Objective: To evaluate the efficiency of…

Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study

August 15, 2024 | Comments Off on Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study

Acta Oncologica 2024 August 8 [Link] Jens Benn Sørensen, Paul Baas, Szimonetta Komjáthiné Szépligeti, Alma B Pedersen, Søren P Johnsen, Robert Carroll, Minouk J Schoemaker, Caroline Rault, Melinda J Daumont,…

Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors

August 14, 2024 | Comments Off on Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors

PLoS One 2024 August 8 [Link] Masaki Ito, Shigeo Koido, Takeo Iwamoto, Soyoko Morimoto, Fumihiro Fujiki, Haruo Sugiyama, Saki Matsumoto, Clara Effenberger, Kazuma Kiyotani, Kiyotaka Shiba Abstract The immunogenicity of…

Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment

August 13, 2024 | Comments Off on Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment

Scientific Reports 2024 August 6 [Link] Darya Karatkevich, Tereza Losmanova, Philipp Zens, Haibin Deng, Christelle Dubey, Tuo Zhang, Corsin Casty, Yanyun Gao, Christina Neppl, Sabina Berezowska, Wenxiang Wang, Ren-Wang Peng,…

Application of the international system for reporting serous fluid cytopathology on pleural effusion cytology with paired pleural biopsy: A new insight and novel approach on risk of malignancy

August 12, 2024 | Comments Off on Application of the international system for reporting serous fluid cytopathology on pleural effusion cytology with paired pleural biopsy: A new insight and novel approach on risk of malignancy

Cytopathology 2024 August 1 [Link] Zahra Maleki, Ashleigh J Graham, Robert Jones, Ricardo Pastorello, Paul Morris, Alessandra C Schmitt, Erika F Rodriguez Abstract Introduction: The risk of malignancy (ROM) remains…

Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment

August 9, 2024 | Comments Off on Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment

Cancer Biotherapy & Radiopharmaceuticals 2024 August 2 [Link] Yi-Tong Liu, He-Liang Wu, Yan-Dong Su, Yi Wang, Yan Li Abstract Malignant peritoneal mesothelioma (MPeM) is a rare primary malignant tumor originating…

Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature

August 8, 2024 | Comments Off on Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature

Frontiers in Oncology 2024 July 18 [Link] Marie-Florence Reveneau, Julien Masliah-Planchon, Manuel Fernandez, Abdenour Ouikene, Bernard Dron, Innocenti Dadamessi, Charles Dayen, Lisa Golmard, Bruno Chauffert Abstract Malignant peritoneal mesothelioma (MPM)…

Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review

August 7, 2024 | Comments Off on Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review

Journal of Surgical Oncology 2024 July 31 [Link] Xin-Li Liang, Xin-Bao Li, Yu-Bin Fu, Yan-Dong Su, Ru Ma, Rui Yang, He-Liang Wu, Yan Li Abstract Malignant peritoneal mesothelioma (MPM) is…

Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms

August 6, 2024 | Comments Off on Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms

ESMO Open 2024 July 25 [Link] N Benzerdjeb, P Dartigues, V Kepenekian, F Damiola, R Sequeiros, F Galateau-Salle, H Begueret, E Mery, D Damotte, V Verriele, J Fontaine, S Isaac,…

Categories